IMMUNOGEN INC Business Operations Contracts & Agreements
11 Contracts & Agreements
- Collaboration Agreements (8 contracts)
- Development Agreements (1)
- Supply Agreements (1)
- Termination Agreements (1)
- Collaboration and License Agreement effective as of October 19, 2020 by and between the registrant and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd., a subsidiary of Huadong... (Filed With SEC on March 1, 2021)
- First Amendment to Collaboration and Option Agreement dated as of November 20, 2019 by and between the Registrant and Jazz Pharmaceuticals Ireland Limited (Filed With SEC on March 11, 2020)
- AMENDMENT NO. 4 TO THE Collaboration and License Agreement (Filed With SEC on August 4, 2017)
- AMENDMENT NO. 3 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on October 30, 2014)
- AMENDMENT NO. 2 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on October 30, 2014)
- AMENDMENT NO. 1 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on October 30, 2014)
- CLINICAL SUPPLY AGREEMENT (Filed With SEC on February 8, 2011)
- AMENDMENT NO. 3 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 6, 2009)
- AMENDMENT NO. 2 TO THE COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on February 7, 2008)
- PROCESS DEVELOPMENT AGREEMENT (Filed With SEC on August 28, 2006)
- TERMINATION OF THEDEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT MADE BETWEEN VERNALIS(R&D) LIMITED (Filed With SEC on May 14, 2004)
